{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:39:02Z","timestamp":1793104742778,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":32,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.phro.2026.101104","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:11:19Z","timestamp":1791151879000},"page":"101104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Trigger-based adaptive proton therapy and changes in target coverage and cardiac dose in esophageal cancer"],"prefix":"10.1016","volume":"41","author":[{"given":"Vlad","family":"Badiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Kneepkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Reijtenbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike","family":"Berb\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Canters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2026.101104_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(25)00027-0","article-title":"Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial","volume":"26","author":"van der Wilk","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0010","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1200\/JCO.20.03614","article-title":"Ten-year outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal cancer: the randomized controlled CROSS trial","volume":"39","author":"Eyck","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0015","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2017.04.013","article-title":"Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer","volume":"123","author":"Lin","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0020","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2013.04.006","article-title":"Predictors of postoperative complications after trimodality therapy for esophageal cancer","volume":"86","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101104_bb0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1245\/s10434-013-3316-8","article-title":"Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients","volume":"21","author":"Bosch","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0030","first-page":"17","article-title":"Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy","volume":"17","author":"Xu","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0035","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/COC.0000000000000573","article-title":"Cardiac toxicity in operable esophageal cancer patients treated with or without chemoradiation","volume":"42","author":"Witt","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0040","first-page":"516","article-title":"Increased risk of death due to heart disease after radiotherapy for esophageal cancer","volume":"6","author":"Frandsen","year":"2015","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0045","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jtho.2020.06.014","article-title":"Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer","volume":"15","author":"Wang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13014-018-0966-5","article-title":"Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma","volume":"13","author":"Hirano","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0055","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ijrobp.2010.07.2001","article-title":"Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study","volume":"81","author":"Welsh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101104_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110409","article-title":"Robustness of intensity modulated proton treatment of esophageal cancer for anatomical changes and breathing motion","volume":"198","author":"Canters","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0065","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.21037\/jtd-2019-cptn-06","article-title":"Proton beam radiotherapy for esophagus cancer: state of the art","volume":"12","author":"Gergelis","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.phro.2026.101104_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.radonc.2020.07.015","article-title":"Weekly robustness evaluation of intensity-modulated proton therapy for oesophageal cancer","volume":"151","author":"Anakotta","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111164","article-title":"National indication protocol for proton radiotherapy in esophageal cancer patients in the Netherlands","volume":"213","author":"Muijs","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/mp.18037","article-title":"Dose accumulation over the treatment course including setup and range uncertainty for proton therapy of esophageal and lung cancer patients","volume":"52","author":"Taasti","year":"2025","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2026.101104_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2024.103386","article-title":"Quantification of deformable image registration uncertainties for dose accumulation on head and neck cancer proton treatments","volume":"122","author":"Amstutz","year":"2024","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2026.101104_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2478\/raon-2022-0016","article-title":"The dose accumulation and the impact of deformable image registration on dose reporting parameters in a moving patient undergoing proton radiotherapy","volume":"56","author":"Razdevsek","year":"2022","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109980","article-title":"Proton versus photon therapy for esophageal cancer \u2013 a trimodality strategy (PROTECT) NCT050555648: a multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer","volume":"190","author":"Mortensen","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0100","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.radonc.2022.04.029","article-title":"Treatment planning comparison in the PROTECT-trial randomising proton versus photon beam therapy in oesophageal cancer: results from eight European centres","volume":"172","author":"Hoffmann","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0105","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2020.11.032","article-title":"Proposal for the delineation of neoadjuvant target volumes in oesophageal cancer","volume":"156","author":"Thomas","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2019.08.005","article-title":"Practical robustness evaluation in radiotherapy \u2013 a photon and proton-proof alternative to PTV-based plan evaluation","volume":"141","author":"Korevaar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0115","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190598","article-title":"Beam commissioning of the first compact proton therapy system with spot scanning and dynamic field collimation","volume":"93","author":"Vilches-Freixas","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.phro.2026.101104_bb0120","first-page":"141","article-title":"Prescribing, Recording, and Reporting Proton-Beam Therapy. ICRU Report 78","volume":"7","author":"International Commission on Radiation Units and Measurements","year":"2007","journal-title":"J ICRU"},{"key":"10.1016\/j.phro.2026.101104_bb0125","article-title":"An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapy","volume":"37","author":"Fracchiolla","year":"2026","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0130","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2021.07.028","article-title":"Accurate assessment of a Dutch practical robustness evaluation protocol in clinical PT with pencil beam scanning for neurological tumors","volume":"163","author":"Rojo-Santiago","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2026.111717","article-title":"Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol","volume":"223","author":"Canters","year":"2026","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2022.11.001","article-title":"Robustness assessment of clinical adaptive proton and photon radiotherapy for oesophageal cancer in the model-based approach","volume":"177","author":"Visser","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0145","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/0284186X.2022.2091949","article-title":"Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer","volume":"61","author":"Shamshad","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0150","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.3109\/0284186X.2015.1068449","article-title":"Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patients","volume":"54","author":"Nyeng","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmp.2026.105778","article-title":"Evaluating the adaptation rates for esophageal cancer: impact of the setup error contribution and of the dosimetric threshold","volume":"145","author":"Draguet","year":"2026","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2026.101104_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13014-020-01664-7","article-title":"Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy","volume":"15","author":"Pao","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101104_bb0165","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190594","article-title":"Online daily adaptive proton therapy","volume":"93","author":"Albertini","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.phro.2026.101104_bb0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626002046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626002046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:27:30Z","timestamp":1793104050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631626002046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S2405631626002046"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2026.101104","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trigger-based adaptive proton therapy and changes in target coverage and cardiac dose in esophageal cancer","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2026.101104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101104"}}